- Book
- October 2020
- 288 Pages
- Book
- January 2016
- 368 Pages
- Book
- April 2015
- 456 Pages
- Book
- May 2024
North America
- Book
- October 2022
North America
- Book
- October 2018
- 458 Pages

Pancreatic cancer is a type of cancer that affects the pancreas, an organ located in the abdomen. It is one of the most aggressive and deadly forms of cancer, with a five-year survival rate of only 9%. It is the fourth leading cause of cancer-related death in the United States.
Treatment for pancreatic cancer typically involves a combination of surgery, chemotherapy, and radiation therapy. Surgery is the most common treatment, and is used to remove tumors and surrounding tissue. Chemotherapy and radiation therapy are used to kill cancer cells that may remain after surgery.
The oncology market for pancreatic cancer is highly competitive, with many companies developing new treatments and therapies. Companies are focusing on developing targeted therapies, immunotherapies, and combination therapies to improve outcomes for patients.
Companies in the pancreatic cancer market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more